Astrana Health Stock Price Prediction
ASTH Stock | 33.47 0.23 0.68% |
Oversold Vs Overbought
30
Oversold | Overbought |
Quarterly Earnings Growth (0.30) | EPS Estimate Next Quarter 0.23 | EPS Estimate Current Year 1.8079 | EPS Estimate Next Year 1.943 | Wall Street Target Price 64.5 |
Using Astrana Health hype-based prediction, you can estimate the value of Astrana Health from the perspective of Astrana Health response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Astrana Health to buy its stock at a price that has no basis in reality. In that case, they are not buying Astrana because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Astrana Health after-hype prediction price | USD 34.05 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Astrana |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Astrana Health's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Astrana Health After-Hype Price Prediction Density Analysis
As far as predicting the price of Astrana Health at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Astrana Health or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Astrana Health, with the unreliable approximations that try to describe financial returns.
Next price density |
Expected price to next headline |
Astrana Health Estimiated After-Hype Price Volatility
In the context of predicting Astrana Health's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Astrana Health's historical news coverage. Astrana Health's after-hype downside and upside margins for the prediction period are 30.53 and 37.57, respectively. We have considered Astrana Health's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Astrana Health is very steady at this time. Analysis and calculation of next after-hype price of Astrana Health is based on 3 months time horizon.
Astrana Health Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Astrana Health is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Astrana Health backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Astrana Health, there might be something going there, and it might present an excellent short sale opportunity.
Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.74 | 3.52 | 0.58 | 0.49 | 9 Events / Month | 5 Events / Month | In about 9 days |
Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
33.47 | 34.05 | 1.73 |
|
Astrana Health Hype Timeline
Astrana Health is presently traded for 33.47. The entity has historical hype elasticity of 0.58, and average elasticity to hype of competition of 0.49. Astrana is anticipated to increase in value after the next headline, with the price projected to jump to 34.05 or above. The average volatility of media hype impact on the company the price is over 100%. The price growth on the next news is projected to be 1.73%, whereas the daily expected return is presently at -0.74%. The volatility of related hype on Astrana Health is about 534.49%, with the expected price after the next announcement by competition of 33.96. The company reported the previous year's revenue of 1.39 B. Net Income was 57.85 M with profit before overhead, payroll, taxes, and interest of 199.48 M. Given the investment horizon of 90 days the next anticipated press release will be in about 9 days. Check out Astrana Health Basic Forecasting Models to cross-verify your projections.Astrana Health Related Hype Analysis
Having access to credible news sources related to Astrana Health's direct competition is more important than ever and may enhance your ability to predict Astrana Health's future price movements. Getting to know how Astrana Health's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Astrana Health may potentially react to the hype associated with one of its peers.
HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
BNTX | BioNTech SE | 5.85 | 10 per month | 2.55 | 0.01 | 4.79 | (4.00) | 11.96 | |
VLN | Valens | 0.06 | 8 per month | 0.00 | (0.02) | 8.33 | (6.82) | 25.09 | |
ARW | Arrow Electronics | 1.00 | 12 per month | 0.00 | (0.11) | 2.39 | (1.80) | 15.36 | |
INBX | Inhibrx | (0.23) | 5 per month | 0.00 | (0.07) | 4.72 | (3.75) | 11.96 | |
ELTK | Eltek | 0.07 | 6 per month | 0.00 | (0.01) | 3.75 | (5.36) | 15.54 | |
APGE | Apogee Therapeutics, Common | (0.38) | 8 per month | 0.00 | (0.07) | 5.62 | (7.37) | 21.79 | |
SYRE | Spyre Therapeutics | (1.76) | 9 per month | 0.00 | (0.08) | 5.30 | (8.31) | 16.36 |
Astrana Health Additional Predictive Modules
Most predictive techniques to examine Astrana price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Astrana using various technical indicators. When you analyze Astrana charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
About Astrana Health Predictive Indicators
The successful prediction of Astrana Health stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Astrana Health, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Astrana Health based on analysis of Astrana Health hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Astrana Health's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Astrana Health's related companies. 2021 | 2022 | 2023 | 2024 (projected) | Dividend Yield | 0.009653 | 0.0105 | 0.0343 | 0.0428 | Price To Sales Ratio | 4.16 | 1.16 | 1.31 | 1.33 |
Story Coverage note for Astrana Health
The number of cover stories for Astrana Health depends on current market conditions and Astrana Health's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Astrana Health is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Astrana Health's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Astrana Health Short Properties
Astrana Health's future price predictability will typically decrease when Astrana Health's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Astrana Health often depends not only on the future outlook of the potential Astrana Health's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Astrana Health's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding | 47.1 M | |
Cash And Short Term Investments | 296.3 M |
Complementary Tools for Astrana Stock analysis
When running Astrana Health's price analysis, check to measure Astrana Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Astrana Health is operating at the current time. Most of Astrana Health's value examination focuses on studying past and present price action to predict the probability of Astrana Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Astrana Health's price. Additionally, you may evaluate how the addition of Astrana Health to your portfolios can decrease your overall portfolio volatility.
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
Stocks Directory Find actively traded stocks across global markets | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk |